Clinical Trials

Showing 421 - 440 of 512 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of MEDI4736 in Patients with Advanced Solid Tumors
[Protocol 12-179]
Segal, Neil
  • Colorectal Cancer
  • Kidney Cancer
  • Lung Cancer, Non-Small Cell
  • Melanoma
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew
  • Brain Tumors, Metastatic
  • Breast Cancer
A Phase II Study of Sorafenib Alone and with Everolimus in Patients with Hurthle Cell Thyroid Cancer that Does Not Response to Radioactive Iodine Therapy
[Protocol 14-118]
Sherman, Eric
  • Thyroid Cancer
A Phase II Study of Concurrent Intensity-Modulated Radiation Therapy (IMRT), Paclitaxel, and Pazopanib/Placebo for the Treatment of Anaplastic Thyroid Cancer
[Protocol 10-186]
Sherman, Eric
  • Thyroid Cancer
A Phase III Study of Vandetanib in Patients with Locally Advanced or Metastatic Papillary Thyroid Cancer Who Cannot Be Successfully Treated with Radioiodine
[Protocol 13-245]
Sherman, Eric
  • Thyroid Cancer
A Phase I Study of Dabrafenib plus Lapatinib to Treat Inoperable Thyroid Cancers with Abnormal BRAF
[Protocol 13-061]
Sherman, Eric
  • Thyroid Cancer
Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia
[Protocol 11-002]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of EPZ-5676 to Treat Children with Recurrent or Persistent MLL-Mutant Acute Leukemia
Relapsed/Refractory
[Protocol 14-080]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib
[Protocol 11-030]
Shukla, Neerav
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Chronic Myelocytic Leukemia
ALTE03N1: Key Adverse Events Following Childhood Cancer
[Protocol 05-070]
Sklar, Charles
  • Survivorship
A Phase II Study of Abiraterone with or without Cabazitaxel in Patients with Metastatic Castration-Resistance Prostate Cancer
[Protocol 14-046]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
Adoptive Transfer of Autologous T Cells Targeted to Prostate-Specific Membrane Antigen for the Treatment of Metastatic Castration-Resistant Prostate Cancer
[Protocol 09-036]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase IV Study of Enzalutamide in Men with Metastatic Prostate Cancer Who Are at Risk for Seizures
[Protocol 13-231]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study Comparing Romiplostim with Observation for Chemotherapy-Induced Thrombocytopenia
[Protocol 13-132]
Soff, Gerald
  • Hematology
    • Hematologic Disorders
  • Solid Tumors
Examination of Tissue from Ablated Malignant Liver Metastases to Predict Outcome
[Protocol 09-122]
Sofocleous, Constantinos
  • Colorectal Cancer
    • Colon Cancer
  • Liver Metastases
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011]
Souweidane, Mark
  • Pediatric Brain Tumors
    • Brain Cancer
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068]
Stadler, Zsofia
  • Breast Cancer
  • Colorectal Cancer
    • Colon Cancer
    • Rectal Cancer
  • Germ Cell Tumors
  • Hereditary Cancer & Genetics
  • Neuroblastoma
  • Primary Bone
    • Osteosarcoma
  • Sarcomas
    • Osteosarcoma
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients
[Protocol 04-144]
Stadler, Zsofia
  • Colorectal Cancer
    • Colon Cancer
  • Hereditary Cancer & Genetics
  • Psychiatry & Behavioral Sciences
A Phase I Study of Oral AG-120 to Treat Advanced Acute Myeloid Leukemia or Myelodysplastic Syndromes with an IDH1 Mutation
[Protocol 14-052]
Stein, Eytan
  • Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of CPI-0610 in Patients with Acute Leukemia, Myelodysplastic Syndromes, or Myelodysplastic/Myeloproliferative Neoplasms
[Protocol 14-136]
Stein, Eytan
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelocytic Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
    • Myeloproliferative Neoplasm